Conventional T1/T2-weighted magnetic resonance imaging (cMRI) is the method of choice for diagnosis and treatment monitoring of multiple sclerosis (MS), though not being able to explain underlying pathological processes. In contrast to cMRI-lesions, which only reflect the severity of irreversible tissue damage, MR Spectroscopic Imaging (MRSI) can detect pathologies on a biochemical level. In 51 relapsing-remitting (RRMS) patients, we investigate - enabled through ultra-high resolution FID-MRSI at 7T - the metabolic distribution within lesions and their vicinity as well as their location dependency and correlation to T1-hypointensity.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords